ASBP

ASBP

NASDAQ

Aspire Biopharma Holdings, Inc.

0.5449

-0.6451(-54.21%)
Volume

5.0M

Market Cap

$1.89M

P/E Ratio

-0.32

EPS

$-16.38


Price Chart

Price Alerts

No price alerts set. Add an alert to get notified!

Notify when price goes above $120.00
Notify when price goes above $180.00
Notify when price goes below $180.00

Key Financial Ratios

P/E Ratio

-0.32

P/B Ratio

-1.24

EPS

$-16.38

ROE

383.93%

Profit Margin

-394,725.06%

Operating Margin

-312,016.95%

Peer Comparison

Compare TSM with similar companies in the sector

Company Price Change % P/E Market Cap D/E
ANNA
AleAnna, Inc.
$4.17 -0.71% 94.18 $169.55M 0.05
BOCN
Blue Ocean Acquisition Corp.
$10.72 0.00 47.52 $70.57M 0.02
CAUD
Collective Audience, Inc.
$0.01 0.50% -0.03 $2.01M 1.38
CHAA
Catcha Investment Corp
$8.90 7.23% -19.11 $77.57M 0.46
CSLM
Consilium Acquisition Corp I, Ltd.
$11.69 0.00 -7.39 $71.50M 0.00
FIAC
Focus Impact Acquisition Corp.
$8.88 -10.48% -7.60 $66.31M 0.00
GAMC
Golden Arrow Merger Corp.
$9.00 -22.41% -2.80 $68.63M 0.00
INAQ
Insight Acquisition Corp.
$9.50 -16.45% -32.34 $61.93M -1.41
LIVB
LIV Capital Acquisition Corp. II
$10.97 0.05% 416.70 $73.34M 0.03
WEL
Integrated Wellness Acquisition Corp
$11.86 -0.59% -12.57 $84.56M 0.00

* Peer stocks are selected based on market capitalization and sector

Private Notes

Key Statistics

52 Week High

$35.00

52 Week Low

$0.52

Dividend

$0.00

Dividend Yield

0.00%

About Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers Instaprin, a sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, including a melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.